Create Fertility, Birmingham, UK.
Create Fertility, London, UK.
Hum Reprod. 2024 Nov 1;39(11):2491-2500. doi: 10.1093/humrep/deae198.
Does advanced male partner's age impact live birth rates (LBRs) in IVF treatment when female partner's age is factored in?
In fresh IVF cycles LBRs decline with male partner's age ≥40 years when the female partner is aged 35-39 years, irrespective of the presence or absence of male factor; but not when the female partner is <35 years or ≥40 years of age; this decline is not observed in ICSI cycles.
Advanced paternal age is associated with declining sperm parameters, impaired embryo development, compromised pregnancy outcomes, and abnormalities in the offspring in IVF/ICSI cycles. However, data on the interaction between maternal and paternal age on IVF outcomes are very limited and inconsistent. No significant effect of male partner's age on pregnancy outcomes has been noted in donor oocyte cycles.
STUDY DESIGN, SIZE, DURATION: Retrospective analysis of all eligible autologous IVF/ICSI cycles with oocyte retrieval and intended fresh embryo transfer (ET) from the UK's national anonymized registry, published online by the Human Fertilisation and Embryology Authority (HFEA). There were 59 951 cycles that qualified the inclusion criteria in the study period: 1 January 2017 to 31 December 2018.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Couples underwent IVF (n = 27 226) or ICSI (n = 32 725) treatment with partner's sperm followed by fresh ET due to unexplained (n = 31 846), tubal (n = 6605), or male infertility (n = 22 905). Treatment cycles with endometriosis (n = 5563), ovulatory disorders (n = 9970), female partner aged >44 years (n = 636), and PGT (n = 280) were excluded. Women were stratified by age in the following groups: <35, 35-39, 40-42, and 43-44 years; male partner's age as <35 (reference group), 35-37, 38-39, 40-42, 43-44, 45-50, 51-55, 55-60, and >55 years as presented by the HFEA. Some age-groups were merged in the analysis to increase the population size. Chi-square test was used to compare binominal data; and multiple logistic regression to find any association between male and female age-groups on live birth adjusting for other confounders that had a significant effect on this outcome.
LBRs per oocyte retrieval as well as per ET were no different across the male partners' age-groups when the female partners were aged <35 years or in 40- to 44-year age-group, whether male-factor infertility was included or excluded and whether it was IVF or ICSI cycle. However, when IVF was the method of insemination in the female partner's age-group of 35-39 years, LBRs per oocyte retrieval dropped significantly from 27.0% in the male age-group of <35 years (reference group) to 22.9% (P = 0.002), 22.0% (P = 0.006), and 18.8% (P = 0.004) in 40-44, 45-50, and >50 years age-group, respectively in population that included male-factor infertility. Likewise, LBR per retrieval declined from 27.6% in 35 years age-group to 23.5% (P = 0.002) and 22.2% (P = 002) in 40-44 years and older groups, respectively in cycles without male infertility. However, there was no impact of male age on LBR in any female partner's age-group when ICSI was performed in either the presence or the absence of male infertility. A similar decline in the LBR per retrieval and per ET was observed in female age-group of 35-39 years in the analyses with IVF and ICSI cycles combined. The inference remained unchanged when only the first treatment cycle was included (per patient analysis) or when single blastocyst transfer cycles were analysed, eliminating the impact of the number and stage of embryo transferred. After adjusting for confounders including male age, female age, number of previous treatment cycles, previous live birth, insemination method (IVF or ICSI), number of embryos transferred, and day (stage) of ET, male partner's age remained significantly associated with LBR in the female age-group of 35-39 years, but not when women were in <35 years or 40- to 44-year age-group, in population including as well as excluding male infertility. Miscarriage rates per single ET trended to rise (non-significantly) in IVF as well as ICSI cycle only when men were over 55 years and female partners aged <40 years, particularly when male infertility was excluded.
LIMITATIONS, REASONS FOR CAUTION: Information on ovarian reserve and stimulation protocols was not available. This probably would have had little impact, given the large size of the population studied. The ages of female and male partners were given in groups necessitating taking them as ordinal variable in the regression analysis. Cumulative LBRs could not be determined as the information on subsequent frozen-thawed ET cycles could not be traced and the severity or cause of abnormal semen parameters were not present in the HFEA database. Some age-groups with small number of patients were merged to obtain a reliable result.
This is the largest clinical data to support the laboratory evidence of the ability of oocytes from young women to reverse the age-related deterioration of sperm quality. As the ageing oocytes lose this reparatory mechanism, the ageing sperm exert a detrimental effect on the LBR. The message of this study is important in counselling of patients and planning out treatment. Further research on interaction between male and female age will increase our understanding of this matter and help to establish whether ICSI procedure is more appropriate for older male partners even when there is no apparent semen abnormality.
STUDY FUNDING/COMPETING INTEREST(S): No funding was required. There is no competing interest.
N/A (retrospective analysis).
当考虑女性伴侣的年龄因素时,男性伴侣的年龄是否会影响体外受精(IVF)治疗中的活产率(LBR)?
在新鲜 IVF 周期中,当女性伴侣年龄为 35-39 岁时,无论是否存在男性因素,伴侣年龄≥40 岁的男性 LBR 会随着年龄的增长而下降;但当女性伴侣年龄<35 岁或≥40 岁时,LBR 不会下降;在 ICSI 周期中未观察到这种下降。
高龄父亲与精子参数下降、胚胎发育受损、妊娠结局恶化以及 IVF/ICSI 周期中后代异常有关。然而,关于母体和父体年龄对 IVF 结局相互作用的数据非常有限且不一致。在供体卵母细胞周期中,未观察到男性伴侣年龄对妊娠结局有显著影响。
研究设计、规模、持续时间:对英国国家匿名注册机构公布的所有符合纳入标准的有卵母细胞回收和计划进行新鲜胚胎移植(ET)的自体 IVF/ICSI 周期进行回顾性分析。研究期间有 59951 个周期符合纳入标准:2017 年 1 月 1 日至 2018 年 12 月 31 日。
参与者/材料、设置、方法:由于不明原因(n=31846)、输卵管(n=6605)或男性不育(n=22905),夫妇接受了 IVF(n=27226)或 ICSI(n=32725)治疗,随后进行新鲜 ET。排除子宫内膜异位症(n=5563)、排卵障碍(n=9970)、女性伴侣年龄>44 岁(n=636)和 PGT(n=280)治疗周期。根据以下年龄组对女性进行分层:<35、35-39、40-42 和 43-44 岁;男性伴侣年龄<35(参考组)、35-37、38-39、40-42、43-44、45-50、51-55、55-60 和>55 岁,如 HFEA 所示。为了增加研究人群的规模,对一些年龄组进行了合并。使用卡方检验比较二项式数据;使用多因素逻辑回归分析,当女性年龄<35 岁或在 40-44 岁年龄组时,无论男性因素不育是否存在以及是否为 IVF 或 ICSI 周期,男性和女性年龄组之间的活产率(LBR)是否存在关联,以其他对该结局有显著影响的混杂因素进行调整。
当女性伴侣年龄<35 岁或在 40-44 岁年龄组时,无论男性因素不育是否存在以及是否为 IVF 或 ICSI 周期,男性伴侣年龄组的 LBR 与卵母细胞回收或 ET 无关。然而,当 IVF 为女性伴侣 35-39 岁时的授精方法时,LBR 从男性年龄组<35 岁(参考组)的 27.0%显著下降至 40-44 岁、45-50 岁和>50 岁年龄组的 22.9%(P=0.002)、22.0%(P=0.006)和 18.8%(P=0.004)。同样,在无男性不育的周期中,LBR 从 35 岁年龄组的 27.6%下降至 40-44 岁和>40 岁年龄组的 23.5%(P=0.002)和 22.2%(P=0.002)。然而,当 ICSI 用于无论是否存在男性不育时,男性年龄对任何女性年龄组的 LBR 均无影响。在合并 IVF 和 ICSI 周期的女性年龄组 35-39 岁的分析中,也观察到 LBR 回收和 ET 的相似下降。当仅包括第一次治疗周期(每位患者分析)或仅分析单个囊胚转移周期时,这种推断仍然不变,从而消除了转移胚胎的数量和阶段的影响。调整混杂因素包括男性年龄、女性年龄、以前的治疗周期数、以前的活产率、授精方法(IVF 或 ICSI)、转移的胚胎数和 ET 日(阶段)后,男性伴侣的年龄在包括和不包括男性不育的女性年龄组 35-39 岁时与 LBR 仍显著相关,但在女性年龄组<35 岁或 40-44 岁时,与 LBR 无关。IVF 和 ICSI 周期中仅当男性年龄超过 55 岁且女性年龄<40 岁时,胚胎移植次数增加(无显著意义),尤其是当排除男性不育时,单 ET 的流产率呈上升趋势。
局限性、谨慎的原因:卵巢储备和刺激方案的信息不可用。鉴于研究人群规模庞大,这可能影响不大。女性和男性伴侣的年龄以组的形式呈现,因此在回归分析中需要将其视为有序变量。由于无法追踪随后的冷冻-解冻 ET 周期的信息,并且无法在 HFEA 数据库中获得异常精液参数的严重程度或原因,因此无法确定累积 LBR。一些患者人数较少的年龄组被合并,以获得可靠的结果。
这是支持实验室证据的最大临床数据,即年轻女性的卵子有能力逆转与精子质量相关的年龄相关恶化。随着老化卵子失去这种修复机制,老化精子对 LBR 产生有害影响。本研究的信息对患者咨询和治疗计划非常重要。进一步研究男性和女性年龄之间的相互作用将增加我们对这一问题的理解,并有助于确定 ICSI 程序是否更适合即使存在明显精液异常的老年男性伴侣。
研究资金/利益冲突:无需资金。没有利益冲突。
N/A(回顾性分析)。